For: | Sanchez-Pareja A, Clément S, Peyrou M, Spahr L, Negro F, Rubbia-Brandt L, Foti M. Phosphatase and tensin homolog is a differential diagnostic marker between nonalcoholic and alcoholic fatty liver disease. World J Gastroenterol 2016; 22(14): 3735-3745 [PMID: 27076758 DOI: 10.3748/wjg.v22.i14.3735] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i14/3735.htm |
Number | Citing Articles |
1 |
Flavien Berthou, Cyril Sobolewski, Daniel Abegg, Margot Fournier, Christine Maeder, Dobrochna Dolicka, Marta Correia de Sousa, Alexander Adibekian, Michelangelo Foti. Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk. International Journal of Molecular Sciences 2022; 23(7): 3959 doi: 10.3390/ijms23073959
|
2 |
Weiping Li, Xiaoge Chen, Miaozhi Lin, Dongyang Huang. Up-regulated HOTAIR induced by fatty acids inhibits PTEN expression and increases triglycerides accumulation in HepG2 cells. Food & Nutrition Research 2017; 61(1): 1412794 doi: 10.1080/16546628.2017.1412794
|
3 |
Cyril Sobolewski, Daniel Abegg, Flavien Berthou, Dobrochna Dolicka, Nicolas Calo, Christine Sempoux, Margot Fournier, Christine Maeder, Anne-Sophie Ay, Pierre-Alain Clavien, Bostjan Humar, Jean-François Dufour, Alexander Adibekian, Michelangelo Foti. S100A11/ANXA2 belongs to a tumour suppressor/oncogene network deregulated early with steatosis and involved in inflammation and hepatocellular carcinoma development. Gut 2020; 69(10): 1841 doi: 10.1136/gutjnl-2019-319019
|
4 |
Dina G. Tiniakos, Quentin M. Anstee, Elizabeth M. Brunt, Alastair D. Burt. MacSween's Pathology of the Liver. 2024; : 330 doi: 10.1016/B978-0-7020-8228-3.00005-3
|
5 |
Min Tang, Xiaohui Wei, Yunqin Ma, Yijiong Tan, Han Cao, Shuangshuang Yao, Jiaqi Wang, Hua Yang, Fang Liu, Yongde Peng, Nengguang Fan. USP13 ameliorates metabolic dysfunction-associated steatohepatitis through targeting PTEN. Life Sciences 2025; 360: 123264 doi: 10.1016/j.lfs.2024.123264
|
6 |
Sophie Clément, Cyril Sobolewski, Diana Gomes, Angela Rojas, Nicolas Goossens, Stéphanie Conzelmann, Nicolas Calo, Francesco Negro, Michelangelo Foti. Activation of the oncogenic miR‐21‐5p promotes HCV replication and steatosis induced by the viral core 3a protein. Liver International 2019; 39(7): 1226 doi: 10.1111/liv.14112
|
7 |
Ulas Emre Akbulut. Biomarkers in Nutrition. Biomarkers in Disease: Methods, Discoveries and Applications 2022; : 1 doi: 10.1007/978-3-030-81304-8_30-1
|
8 |
Tianyu He, Xiaoyun Zhang, Jianyu Hao, Shigang Ding. Phosphatase and Tensin Homolog in Non-neoplastic Digestive Disease: More Than Just Tumor Suppressor. Frontiers in Physiology 2021; 12 doi: 10.3389/fphys.2021.684529
|
9 |
Monika Gjorgjieva, Cyril Sobolewski, Dobrochna Dolicka, Marta Correia de Sousa, Michelangelo Foti. miRNAs and NAFLD: from pathophysiology to therapy. Gut 2019; 68(11): 2065 doi: 10.1136/gutjnl-2018-318146
|
10 |
Farooq Riaz, Qian Chen, Kaikai Lu, Ezra Kombo Osoro, Litao Wu, Lina Feng, Rong Zhao, Luyun Yang, Yimeng Zhou, Yingli He, Li Zhu, Xiaojuan Du, Muhammad Sadiq, Xudong Yang, Dongmin Li. Inhibition of miR‐188‐5p alleviates hepatic fibrosis by significantly reducing the activation and proliferation of HSCs through PTEN/PI3K/AKT pathway. Journal of Cellular and Molecular Medicine 2021; 25(8): 4073 doi: 10.1111/jcmm.16376
|
11 |
Xiaolin Luo, Rui Liao, Kaisa L. Hanley, Helen He Zhu, Kirsten N. Malo, Carolyn Hernandez, Xufu Wei, Nissi M. Varki, Nazilla Alderson, Catherine Chu, Shuangwei Li, Jia Fan, Rohit Loomba, Shuang-Jian Qiu, Gen-Sheng Feng. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. Cell Reports 2016; 17(11): 2979 doi: 10.1016/j.celrep.2016.11.048
|
12 |
Yi-Ming Li, Hong-Wei He, Na Zhang. Targeting Protein Phosphatases for the Treatment of Chronic Liver
Disease. Current Drug Targets 2024; 25(3): 171 doi: 10.2174/0113894501278886231221092522
|
13 |
Ulas Emre Akbulut. Biomarkers in Nutrition. Biomarkers in Disease: Methods, Discoveries and Applications 2022; : 517 doi: 10.1007/978-3-031-07389-2_30
|